Apotex

TORONTO, Ontario, June 30, 2026 Apotex Health Corp. announced that Health Canada has approved SEVMIA™ (semaglutide injection), making it...

WESTON, FLORIDA, April 27, 2026 Apotex has secured U.S. Food and Drug Administration (FDA) approval for its generic Infuvite®...

TORONTO, April 23, 2026 Apotex Inc. and Cumberland Pharmaceuticals Inc. announced a strategic transaction to integrate Cumberland’s U.S. branded...

WESTON, FLORIDA, USA, April 14, 2026 Apotex Corp., in collaboration with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma...

MIRAMAR, Fla., April 9, 2026 DifGen Pharmaceuticals LLC, in collaboration with Apotex Inc., has announced that the U.S. Food...

TORONTO, Ontario, Canada, April 7, 2026 Apotex Inc., a leading global pharmaceutical company, announced that Health Canada has approved...